Non-Communicable Diseases in Community Medicine
Learning Objectives
By the end of this topic, you should be able to:
- Define non-communicable diseases and list the four major NCD groups responsible for most global NCD mortality.
- Explain the shared behavioural and metabolic risk factors that link cardiovascular disease, diabetes, cancer, and chronic respiratory disease.
- Describe primary, secondary, and tertiary prevention strategies for major NCDs, including specific screening programs.
- Recall key WHO frameworks (STEPS, FCTC, Global Monitoring Framework, "25x25" targets) used in NCD surveillance and control.
- Apply population-level and individual-level prevention concepts to community health scenarios.
- Distinguish between modifiable and non-modifiable NCD risk factors and explain why this distinction matters for public health policy.
Quick Answer
Non-communicable diseases (NCDs) are chronic, non-transmissible conditions caused by a combination of genetic, physiological, environmental, and behavioural factors rather than infectious agents. The four major NCD groups — cardiovascular disease, cancer, chronic respiratory disease, and diabetes — together cause about 74% of all deaths worldwide (WHO, 2023), with over 80% of premature NCD deaths occurring in low- and middle-income countries. They matter to community medicine because most of this burden is preventable: four modifiable risk factors (tobacco use, unhealthy diet, physical inactivity, and harmful alcohol use) drive the majority of cases. Public health strategy therefore focuses on population-wide risk factor reduction, opportunistic screening, and strengthening primary care to catch disease early, rather than treating NCDs only after complications appear.
Overview
Think of NCDs as the "slow burn" diseases — they build up over years or decades through repeated exposure to risk factors, unlike communicable diseases which spread rapidly through a pathogen. This is exactly why community medicine treats them differently: you cannot vaccinate your way out of diabetes, but you can shift population-level behaviour through policy, screening, and health education.
The WHO groups NCDs into four major categories that account for the overwhelming majority of NCD deaths: cardiovascular diseases (~17.9 million deaths/year, the single largest killer), cancers (~9.3 million), chronic respiratory diseases (~4.1 million), and diabetes (~2 million, including diabetes-related kidney disease). Notice that these four diseases don't operate independently — a patient with obesity and physical inactivity is simultaneously at risk for hypertension, type 2 diabetes, and certain cancers. This clustering of risk is why NCD prevention programs target shared risk factors rather than running four separate disease-specific campaigns.
For exams, the essential framing is this: NCDs are largely preventable through modification of four behavioural risk factors (tobacco, alcohol, unhealthy diet, physical inactivity) which produce four intermediate metabolic risk factors (raised blood pressure, raised blood glucose, abnormal blood lipids, and obesity), which in turn cause the four major disease groups. This "4-4-4" model appears repeatedly in WHO documents and PSM exam questions.
Major Non-Communicable Diseases
Cardiovascular Diseases (CVDs)
Definition: CVDs are disorders of the heart and blood vessels, including coronary artery disease, cerebrovascular disease (stroke), peripheral artery disease, and heart failure.
Explanation: Atherosclerosis — the gradual buildup of fatty plaques in arterial walls — is the underlying process for most CVDs. Chronic exposure to hypertension, dyslipidemia, hyperglycemia, and tobacco smoke damages the endothelium, promoting plaque formation. When a plaque ruptures, it triggers thrombosis, which can occlude a coronary artery (myocardial infarction) or a cerebral artery (ischemic stroke).
Example: A patient with long-standing untreated hypertension develops left ventricular hypertrophy, which progresses to heart failure over 15-20 years — a textbook illustration of a modifiable risk factor causing irreversible structural damage.
Real-world example: India's National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) screens adults over 30 at sub-centres for hypertension and diabetes using simple blood pressure cuffs and glucometers — an example of opportunistic screening embedded into routine primary care rather than a separate specialist visit.
Why it matters: CVD is the single leading cause of death worldwide (~17.9 million deaths/year), and most cases are attributable to modifiable risk factors — meaning population-level prevention has enormous potential impact.
Common misunderstanding: Students often think CVD risk is mainly genetic. In reality, the INTERHEART study (2004) found that nine modifiable risk factors (abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, poor diet, physical inactivity, alcohol) account for about 90% of the population-attributable risk for myocardial infarction — genetics plays a smaller role than commonly assumed.
Prevention strategies:
- Primary: 150 minutes/week moderate aerobic activity, diet low in saturated/trans fat and sodium, tobacco cessation, limiting alcohol
- Secondary: opportunistic BP and lipid screening from age 30, aspirin/statins in high-risk individuals
- Tertiary: cardiac rehabilitation, revascularization (angioplasty/bypass) for established disease
Diabetes Mellitus
Definition: A metabolic disorder characterized by chronic hyperglycemia resulting from defective insulin secretion (Type 1), insulin resistance (Type 2), or both.
Explanation: In Type 2 diabetes — which accounts for roughly 90-95% of cases — peripheral tissues become resistant to insulin's action, so the pancreas compensates by secreting more insulin. Over years, beta-cell function declines and can no longer compensate, and blood glucose rises. Chronic hyperglycemia then damages small vessels (retinopathy, nephropathy, neuropathy) and large vessels (accelerating atherosclerosis).
Example: A person with a sedentary lifestyle and BMI of 32 develops insulin resistance; fasting plasma glucose gradually creeps from 95 mg/dL (normal) to 110 mg/dL (prediabetes/impaired fasting glucose) to 130 mg/dL (diabetes) over several years — showing the continuum rather than an abrupt onset.
Real-world example: India has more than 100 million people living with diabetes (ICMR-INDIAB study), making it central to NPCDCS screening, which uses random blood glucose testing at the community level to catch undiagnosed cases before complications set in.
Why it matters: Diabetes is a major independent risk factor for CVD, the leading cause of blindness in working-age adults, and a leading cause of kidney failure requiring dialysis — its downstream costs to health systems are enormous.
Common misunderstanding: Many students conflate Type 1 and Type 2 diabetes as differing only in "insulin dependence." Actually, Type 1 is an autoimmune destruction of pancreatic beta cells (usually presenting in childhood/young adulthood with absolute insulin deficiency), while Type 2 is primarily a disorder of insulin resistance with relative deficiency, strongly linked to obesity and physical inactivity — the pathophysiology, not just treatment, differs fundamentally.
Prevention strategies:
- Primary: weight management, reducing refined carbohydrate/sugar intake, regular physical activity
- Secondary: opportunistic screening with fasting/random blood glucose or HbA1c from age 30 (earlier if risk factors present)
- Tertiary: glycemic control (lifestyle + oral agents + insulin), regular screening for retinopathy/nephropathy/foot complications
Cancer
Definition: A group of diseases characterized by uncontrolled cell growth and the potential to invade or spread (metastasize) to other parts of the body.
Explanation: Cancer arises from accumulated mutations in genes controlling cell division, apoptosis, and DNA repair. Some mutations are inherited (e.g., BRCA1/2), but most cancers relevant to public health arise from cumulative exposure to carcinogens — tobacco smoke, alcohol, chronic infections (HPV, hepatitis B/C, H. pylori), and environmental carcinogens — acting over decades.
Example: Chronic HPV infection persists in cervical epithelial cells, disrupting tumour suppressor genes (p53, Rb) over 10-20 years, progressing through dysplasia to invasive cervical cancer — which is why cervical cancer is one of the few cancers preventable through vaccination and screening (Pap smear/VIA).
Real-world example: WHO's global initiative to eliminate cervical cancer sets targets of 90% HPV vaccination coverage in girls by age 15, 70% screening coverage by age 35 and 45, and 90% treatment access — a concrete example of a disease-specific NCD elimination strategy built on prevention plus screening.
Why it matters: An estimated 30-50% of cancers are preventable through avoiding risk factors and implementing evidence-based prevention strategies, and several cancers (cervical, oral, breast) are detectable at a pre-invasive or early stage through low-cost screening.
Common misunderstanding: Students often assume cancer screening means "diagnosing cancer early." Precisely defined, screening aims to detect pre-malignant lesions or early asymptomatic disease in an apparently healthy population — for cervical cancer, Pap smear/VIA primarily detects pre-cancerous dysplasia, which is treatable before it ever becomes cancer.
Prevention strategies:
- Primary: tobacco avoidance, HPV and hepatitis B vaccination, limiting alcohol, maintaining healthy BMI, sun protection
- Secondary: Pap smear/VIA (cervical), mammography (breast, age 50-69 per WHO guidance), oral visual examination
- Tertiary: multidisciplinary treatment (surgery, chemotherapy, radiotherapy, immunotherapy), palliative care
Chronic Respiratory Diseases
Definition: Chronic diseases of the airways and lung structures, the most significant being chronic obstructive pulmonary disease (COPD) and asthma.
Explanation: In COPD, chronic exposure to noxious particles (tobacco smoke, biomass fuel smoke, occupational dust) triggers persistent airway inflammation, leading to progressive, largely irreversible airflow limitation from a combination of small airway narrowing (chronic bronchitis component) and alveolar destruction (emphysema component).
Example: A woman who has cooked over a biomass (wood/dung) stove in a poorly ventilated kitchen for 20 years develops COPD despite never smoking — illustrating that indoor air pollution is a major, under-recognized COPD risk factor in low-resource settings, not just cigarette smoking.
Real-world example: India's National Programme on Climate Change and Human Health and initiatives promoting clean cooking fuel (e.g., LPG distribution schemes) directly target household air pollution as COPD prevention — a housing/energy-policy intervention functioning as a health intervention.
Why it matters: COPD is projected to remain among the leading causes of death globally, and unlike many NCDs it disproportionately affects women in developing countries due to indoor air pollution exposure from cooking.
Common misunderstanding: Students often assume COPD is fully reversible with bronchodilators like asthma. In fact, COPD's airflow limitation is characteristically not fully reversible, distinguishing it from asthma where airflow obstruction is largely reversible with treatment — this distinction is a favourite exam discriminator.
Prevention strategies:
- Primary: smoking cessation/prevention, clean cooking fuel, occupational dust protection
- Secondary: spirometry screening in high-risk/symptomatic individuals
- Tertiary: bronchodilators, pulmonary rehabilitation, long-term oxygen therapy, vaccination against influenza/pneumococcus to prevent exacerbations
Risk Factor Modification: The Population Strategy
Community medicine distinguishes between the high-risk approach (identifying and intervening on individuals already at elevated risk, e.g., treating a patient with a BP of 150/95) and the population approach (shifting the entire distribution of a risk factor downward across a whole community, e.g., a national salt-reduction policy). Geoffrey Rose's key insight — "a large number of people at small risk may give rise to more cases of disease than a small number who are at high risk" — is why WHO's global NCD strategy leans heavily on population-wide measures: tobacco taxation, front-of-pack food labelling, trans-fat bans, and marketing restrictions on unhealthy food to children, alongside individual clinical screening.
WHO's "best buys" for NCD prevention are cost-effective population interventions every PSM student should recognize: tobacco tax increases, smoke-free public places, alcohol tax/marketing restrictions, salt reduction in food, and replacing trans fats with polyunsaturated fats.
National and Global Screening Programs
- NPCDCS (India): National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke — screens adults ≥30 years for hypertension, diabetes, and common cancers (oral, breast, cervical) at sub-centre, PHC, and CHC level through population-based screening using a simple risk-assessment form (CBAC — Community Based Assessment Checklist) under Ayushman Bharat Health and Wellness Centres.
- WHO STEPS survey: a standardized three-step approach (Step 1: questionnaire on behavioural risk factors; Step 2: physical measurements like BP, height, weight; Step 3: biochemical measurements like blood glucose, lipids) used globally to monitor NCD risk factor prevalence.
- WHO Global Monitoring Framework: tracks 9 voluntary global targets and 25 indicators for NCDs, including the flagship "25x25" target — a 25% relative reduction in premature mortality from the four major NCDs by 2025 (later extended toward 2030 under the SDG framework, specifically SDG target 3.4).
- WHO FCTC (Framework Convention on Tobacco Control): the first WHO treaty, focused on demand-reduction (taxation, advertising bans, pack warnings) and supply-reduction measures for tobacco control.
Key Terms
| Term | Definition |
|---|---|
| Non-communicable disease (NCD) | A disease of long duration, generally slow progression, not transmissible person-to-person; caused by genetic, physiological, environmental, and behavioural factors. |
| Modifiable risk factor | A risk factor that can be changed through individual behaviour or policy (e.g., tobacco use, diet, physical activity). |
| Non-modifiable risk factor | A risk factor that cannot be altered (e.g., age, sex, genetic predisposition, family history). |
| Metabolic risk factor | An intermediate physiological change — raised blood pressure, raised blood glucose, abnormal lipids, obesity — that links behavioural risk factors to disease outcomes. |
| Population approach | A prevention strategy that shifts risk factor distribution across an entire community rather than targeting only high-risk individuals (Rose's theorem). |
| Opportunistic screening | Screening performed on individuals who present to a health facility for any reason, rather than through an organized, invited screening program. |
| STEPS survey | WHO's standardized stepwise surveillance tool for collecting NCD risk factor data via questionnaire, physical measurement, and biochemical testing. |
| NPCDCS | India's national program for prevention and control of cancer, diabetes, CVD, and stroke, delivered through primary care. |
| "25x25" target | WHO's global target of a 25% relative reduction in premature NCD mortality, originally set for 2025. |
| Primordial prevention | Preventing the emergence of risk factors themselves in a population (e.g., preventing children from ever starting tobacco use), distinct from primary prevention which reduces risk factors already present. |
Common Mistakes
Misconception 1: "NCDs are diseases of affluent, high-income countries." Why it's wrong: This was true decades ago but the epidemiological transition has shifted the burden dramatically. Correct explanation: Over 80% of premature NCD deaths (before age 70) now occur in low- and middle-income countries, where health systems are least equipped to manage chronic disease, and where risk factors like household air pollution add an extra burden not seen in high-income settings.
Misconception 2: "Since NCDs are chronic and non-infectious, they aren't really a 'public health' priority the way epidemics are." Why it's wrong: This conflates urgency with speed of onset. Correct explanation: NCDs cause about 74% of all global deaths, far more than communicable diseases, and their prevention (via population-level risk factor reduction) is a core function of public health — arguably the field's biggest priority in the 21st century, addressed directly under SDG 3.4.
Misconception 3: "Screening for hypertension or diabetes means only measuring blood pressure or glucose once."
Why it's wrong: A single elevated reading does not establish a diagnosis.
Correct explanation: Screening flags individuals who need confirmatory testing — for example, hypertension diagnosis requires elevated readings on at least two separate occasions, and diabetes screening (raised random or fasting glucose) requires confirmation with a repeat test or HbA1c before diagnosis is made, precisely to avoid overdiagnosis from a single measurement affected by stress or timing.
Comparison and Connections
| Feature | Cardiovascular Disease | Diabetes | Cancer | Chronic Respiratory Disease |
|---|---|---|---|---|
| Leading global mechanism | Atherosclerosis / thrombosis | Insulin resistance or deficiency | Uncontrolled cell proliferation | Chronic airway inflammation |
| Primary modifiable driver | Hypertension, dyslipidemia, smoking | Obesity, physical inactivity | Tobacco, infections (HPV/HBV), alcohol | Smoking, indoor/outdoor air pollution |
| Key screening tool | Blood pressure measurement | Fasting/random blood glucose, HbA1c | Pap smear/VIA, mammography, oral exam | Spirometry |
| Reversibility if caught early | Partially, with risk factor control | Prediabetes is reversible; established diabetes is managed, not cured | Highly curable if pre-invasive/early stage | Airflow limitation in COPD is largely irreversible; asthma is reversible |
| Global death toll (approx./year) | 17.9 million | ~2 million (direct + kidney disease) | 9.3 million | 4.1 million |
Students often confuse primary, secondary, and tertiary prevention across these diseases. Primary prevention stops the risk factor from causing disease (e.g., tobacco cessation before COPD develops). Secondary prevention detects disease early through screening while it's still asymptomatic or pre-invasive (e.g., Pap smear detecting cervical dysplasia). Tertiary prevention limits disability and complications once disease is established (e.g., cardiac rehabilitation after a heart attack). The same three-tier framework applies uniformly across all four NCD groups, which is exactly why it is tested repeatedly across different disease contexts.
Practice Questions
Recall
-
Name the four major NCD groups and the four shared behavioural risk factors that drive them. Answer guidance: CVD, cancer, chronic respiratory disease, diabetes; tobacco use, unhealthy diet, physical inactivity, harmful alcohol use.
-
What does the WHO STEPS survey measure, and in what three steps? Answer guidance: Step 1 – behavioural risk factor questionnaire; Step 2 – physical measurements (BP, height, weight); Step 3 – biochemical measurements (blood glucose, lipids).
Understanding
-
Explain why COPD and asthma are both "chronic respiratory diseases" but are managed with different expectations of reversibility. Answer guidance: Asthma's airflow obstruction is largely reversible with bronchodilators/anti-inflammatory treatment; COPD's airflow limitation is progressive and not fully reversible because it involves structural damage (emphysema) in addition to inflammation, so treatment goals shift from reversal to symptom control and slowing decline.
-
Why does WHO promote a "population approach" alongside a "high-risk approach" for NCD prevention? Answer guidance: Rose's theorem — most cases of disease in a population arise from the large number of people at moderate risk rather than the few at very high risk, so shifting the whole population's risk factor distribution (e.g., salt reduction policy) prevents more disease overall than treating only high-risk individuals.
Application
-
A 45-year-old woman visiting a sub-centre for a minor complaint is found to have a random blood glucose of 160 mg/dL. What should the health worker do next, and what is this an example of? Answer guidance: This is opportunistic screening under NPCDCS; the health worker should refer for a confirmatory fasting plasma glucose or HbA1c test rather than diagnosing diabetes on a single random reading, and initiate lifestyle counselling regardless of confirmation.
-
Design one primary and one secondary prevention measure for reducing cervical cancer burden in a rural district. Answer guidance: Primary — HPV vaccination of girls aged 9-14; Secondary — VIA (visual inspection with acetic acid) or Pap smear screening for women aged 30-49, since VIA is low-cost and feasible where cytology infrastructure is limited.
Analysis
-
Compare the pathophysiological link between obesity and two different NCDs (diabetes and cardiovascular disease). Why does tackling obesity have a disproportionately large public health payoff? Answer guidance: Obesity drives insulin resistance (leading to Type 2 diabetes) and also promotes dyslipidemia, hypertension, and systemic inflammation (accelerating atherosclerosis and CVD) — because it sits upstream of multiple metabolic risk factors, a single intervention (weight reduction) simultaneously lowers risk across several disease categories, making it more efficient than disease-specific interventions.
-
A country reduces its tobacco taxation policy under industry pressure. Using the risk factor pathway model, predict the downstream effects over the next 20 years across all four major NCDs. Answer guidance: Lower tobacco taxes typically increase consumption, particularly among price-sensitive youth and low-income groups; expect rising rates of CVD (via atherosclerosis), several cancers (lung, oral, bladder), and COPD (via chronic airway damage), with diabetes indirectly affected through tobacco's association with insulin resistance — illustrating how a single upstream policy reversal cascades across multiple downstream disease categories, sometimes with a lag of one to two decades before mortality effects become visible in surveillance data.
FAQ
Q1: Are NCDs completely preventable? Not completely — non-modifiable factors like age, sex, and genetic predisposition always contribute some baseline risk. But WHO estimates that a large share of premature NCD deaths are avoidable through modifying the four major behavioural risk factors, so "preventable" refers to substantial risk reduction, not zero risk.
Q2: Why are four specific diseases (CVD, cancer, diabetes, chronic respiratory disease) always grouped together as "the" major NCDs? Because they share the same upstream behavioural and metabolic risk factors and together account for the vast majority of NCD deaths, WHO surveillance, policy targets, and national programs (like NPCDCS) are built around this cluster rather than treating each disease in isolation.
Q3: What's the difference between screening and diagnosis? Screening applies a relatively simple, inexpensive test to an asymptomatic population to flag individuals who might have disease or pre-disease; diagnosis is the definitive confirmation using more specific (often more expensive or invasive) tests in those who screen positive. A positive screening test is never itself a diagnosis.
Q4: Why does household air pollution matter so much for NCDs in countries like India? Because a large proportion of rural households still cook with solid biomass fuels (wood, dung, crop residue) on open stoves, indoor smoke exposure is a major driver of COPD (and contributes to CVD and lung cancer risk) — a risk factor largely absent from typical high-income-country NCD discussions, making it a distinct focus of policy responses like clean cooking fuel schemes.
Q5: How is NCD prevention different from infectious disease control at a program-design level? Infectious disease control often relies on a single high-impact intervention (vaccine, vector control, antibiotic) with relatively short time horizons to see results. NCD prevention requires sustained, multi-sectoral action (taxation, food policy, urban planning, health education) over years to decades because the causal pathway from risk factor exposure to disease is long and involves compounding, often synergistic risk factors rather than a single pathogen.
Quick Revision
- NCDs = chronic, non-transmissible diseases from genetic + environmental + behavioural causes; ~74% of global deaths.
- Four major NCD groups: cardiovascular disease (17.9M deaths/yr), cancer (9.3M), chronic respiratory disease (4.1M), diabetes (~2M).
- Four shared behavioural risk factors: tobacco, unhealthy diet, physical inactivity, harmful alcohol use.
- Four intermediate metabolic risk factors: raised BP, raised blood glucose, abnormal lipids, obesity.
- Over 80% of premature NCD deaths occur in low- and middle-income countries.
- INTERHEART study: 9 modifiable factors explain ~90% of population-attributable risk for MI.
- COPD airflow limitation is largely irreversible; asthma's is largely reversible — key exam differentiator.
- Cervical cancer is preventable via HPV vaccination + screening (VIA/Pap smear) — WHO elimination target: 90-70-90.
- NPCDCS (India): screens adults ≥30 for hypertension, diabetes, and common cancers via CBAC checklist at HWCs.
- WHO STEPS survey: 3 steps — questionnaire, physical measurement, biochemical measurement.
- WHO "25x25" target: 25% relative reduction in premature NCD mortality; tracked under SDG 3.4.
- Population approach (Rose's theorem) targets whole-community risk shift; high-risk approach targets individuals already at elevated risk — both are used together.
Related Topics
Prerequisites
- Basic epidemiology (incidence, prevalence, risk factors)
- Levels of prevention (primary, secondary, tertiary, primordial)
- Screening test principles (sensitivity, specificity, predictive value)
Related Topics
- Tobacco control and the WHO FCTC
- National Health Programmes of India
- Health education and behaviour change communication
- Epidemiological transition
Next Topics
- Mental health and NCDs (psychiatric comorbidity in chronic disease)
- Occupational and environmental health
- Health systems strengthening and universal health coverage